Filamin-A expression in triple-negative breast cancer and its clinical significance
The quest for discovering novel biomarkers of triple-negative breast cancers (TNBCs) is ongoing. By lacking expression of hormonal receptors, this aggressive subtype of breast cancer presents a clinical dilemma with early recurrence, metastases and poor survival outcome. Filamin-A is a recent novel...
Enregistré dans:
Auteur principal: | Abderrahman Ouban |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Taylor & Francis Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d97f3845d79b4b17a40e3ab3cb8c6794 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma
par: Gaoda Ju, et autres
Publié: (2021) -
The global status of research in breast cancer liver metastasis: a bibliometric and visualized analysis
par: Yanlong Shi, et autres
Publié: (2021) -
Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer
par: Jianfeng Ding, et autres
Publié: (2021) -
Identification of circRNA_001846 as putative non–small cell lung cancer biomarker
par: Fan Yang, et autres
Publié: (2021) -
Development of dual‐inducible duet‐expression vectors for tunable gene expression control and CRISPR interference‐based gene repression in Pseudomonas putida KT2440
par: Rahul Gauttam, et autres
Publié: (2021)